These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 1958021)

  • 1. Antibodies against small molecules.
    Clementi ME; Marini S; Condò SG; Giardina B
    Ann Ist Super Sanita; 1991; 27(1):139-43. PubMed ID: 1958021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody production: Low dose immunogen vs. low incorporation hapten using salmeterol as a model.
    Fodey TL; Greer NM; Crooks SR
    Anal Chim Acta; 2009 Apr; 637(1-2):328-32. PubMed ID: 19286047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and characterization of hapten-protein conjugates for antibody production against small molecules.
    Singh KV; Kaur J; Varshney GC; Raje M; Suri CR
    Bioconjug Chem; 2004; 15(1):168-73. PubMed ID: 14733597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the immune response and preparation of antibodies against a large panel of conjugated neurotransmitters and biogenic amines: specific polyclonal antibody response and tolerance.
    Huisman H; Wynveen P; Setter PW
    J Neurochem; 2010 Feb; 112(3):829-41. PubMed ID: 19912471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production and characterization of murine monoclonal antibodies to polypeptide hormones and their fragments.
    Modena D; Racchetti G; Putignano S; Comitti R; Galante YM
    Ann Ist Super Sanita; 1991; 27(1):167-74. PubMed ID: 1659793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The technical problems shoot for the production of anti low molecular weight hapten antibody.
    Watanabe T; Nakasaki H; Kamijou A; Mitomi T; Matsuki H; Kasuga H
    Kitasato Arch Exp Med; 1993 Apr; 65 Suppl():47-55. PubMed ID: 7967380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of different hapten-carrier conjugation ratios and molecular orientations on antibody affinity against a peptide antigen.
    Pedersen MK; Sorensen NS; Heegaard PM; Beyer NH; Bruun L
    J Immunol Methods; 2006 Apr; 311(1-2):198-206. PubMed ID: 16574142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cells specific to hapten carrier but not to carrier alone assist in the production of anti-hapten and anti-carrier antibodies.
    Shimizu T; Osaka Y; Banri-Koike C; Yoshida M; Endo K; Furukawa K; Oda M; Murakami A; Ogawa S; Abe R; Azuma T
    Int Immunol; 2007 Oct; 19(10):1157-64. PubMed ID: 17881502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies against the antibiotics: an overview.
    Nolli ML; Parenti G
    Ann Ist Super Sanita; 1991; 27(1):149-54. PubMed ID: 1958023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HaptenDB: a comprehensive database of haptens, carrier proteins and anti-hapten antibodies.
    Singh MK; Srivastava S; Raghava GP; Varshney GC
    Bioinformatics; 2006 Jan; 22(2):253-5. PubMed ID: 16443637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune response to a hapten of fluorescein isothiocyanate in a single mouse analyzed by two-dimensional affinity electrophoresis.
    Nakamura K; Mimura Y; Takeo K
    Electrophoresis; 1993; 14(1-2):81-7. PubMed ID: 8462521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of group-specific antibodies against sulfonamides.
    Cliquet P; Cox E; Haasnoot W; Schacht E; Goddeeris BM
    J Agric Food Chem; 2003 Sep; 51(20):5835-42. PubMed ID: 13129281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of anti-hapten IgE and IgG antibody responses by isologous anti-idiotypic antibodies against purified anti-carrier (ovalbumin) antibodies in BALB/c mice.
    Blaser K; Nakagawa T; de Weck AL
    J Immunol; 1981 Mar; 126(3):1180-4. PubMed ID: 7462630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of carrier and hapten array on the production of anti-hapten antibodies analyzed by two-dimensional affinity electrophoresis.
    Wang P; Nakamura K
    Electrophoresis; 1998 Jun; 19(8-9):1506-10. PubMed ID: 9694303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carrier-induced epitopic suppression is initiated through clonal dominance.
    Schutze MP; Deriaud E; Przewlocki G; LeClerc C
    J Immunol; 1989 Apr; 142(8):2635-40. PubMed ID: 2467933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conjugation of haptens.
    Lemus R; Karol MH
    Methods Mol Med; 2008; 138():167-82. PubMed ID: 18612607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody engineering toward high-sensitivity high-throughput immunosensing of small molecules.
    Kobayashi N; Oyama H
    Analyst; 2011 Feb; 136(4):642-51. PubMed ID: 21152564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological Activity of the Carrier as a Factor in Immunogen Design for Haptens.
    Ertekin Ö; Akçael E; Kocaağa H; Öztürk S
    Molecules; 2018 Nov; 23(11):. PubMed ID: 30441861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of computer-assisted molecular modeling for immunoassay of low molecular weight food contaminants: A review.
    Xu ZL; Shen YD; Beier RC; Yang JY; Lei HT; Wang H; Sun YM
    Anal Chim Acta; 2009 Aug; 647(2):125-36. PubMed ID: 19591697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Forchlorfenuron-mimicking haptens: from immunogen design to antibody characterization by hierarchical clustering analysis.
    Suárez-Pantaleón C; Mercader JV; Agulló C; Abad-Somovilla A; Abad-Fuentes A
    Org Biomol Chem; 2011 Jul; 9(13):4863-72. PubMed ID: 21562652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.